CO5611165A2 - Composicion farmaceutica dispersable para el trataiento de mastitis y trastornos oticos - Google Patents
Composicion farmaceutica dispersable para el trataiento de mastitis y trastornos oticosInfo
- Publication number
- CO5611165A2 CO5611165A2 CO05094077A CO05094077A CO5611165A2 CO 5611165 A2 CO5611165 A2 CO 5611165A2 CO 05094077 A CO05094077 A CO 05094077A CO 05094077 A CO05094077 A CO 05094077A CO 5611165 A2 CO5611165 A2 CO 5611165A2
- Authority
- CO
- Colombia
- Prior art keywords
- phenylephene
- antibacterial agent
- agent
- administered
- pharmaceutical composition
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 208000004396 mastitis Diseases 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 8
- 238000000034 method Methods 0.000 abstract 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 4
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 208000015181 infectious disease Diseases 0.000 abstract 3
- 230000002458 infectious effect Effects 0.000 abstract 3
- 238000001802 infusion Methods 0.000 abstract 2
- 235000019808 microcrystalline wax Nutrition 0.000 abstract 2
- 239000004200 microcrystalline wax Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 210000000056 organ Anatomy 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 abstract 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 abstract 1
- 229930186147 Cephalosporin Natural products 0.000 abstract 1
- 108010078777 Colistin Proteins 0.000 abstract 1
- FMTDIUIBLCQGJB-UHFFFAOYSA-N Demethylchlortetracyclin Natural products C1C2C(O)C3=C(Cl)C=CC(O)=C3C(=O)C2=C(O)C2(O)C1C(N(C)C)C(O)=C(C(N)=O)C2=O FMTDIUIBLCQGJB-UHFFFAOYSA-N 0.000 abstract 1
- 102000002068 Glycopeptides Human genes 0.000 abstract 1
- 108010015899 Glycopeptides Proteins 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- 108010040201 Polymyxins Proteins 0.000 abstract 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 abstract 1
- 229940126575 aminoglycoside Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 229940125716 antipyretic agent Drugs 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 229940124587 cephalosporin Drugs 0.000 abstract 1
- 150000001780 cephalosporins Chemical class 0.000 abstract 1
- 229960005091 chloramphenicol Drugs 0.000 abstract 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 abstract 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 abstract 1
- 229960003346 colistin Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 229960003760 florfenicol Drugs 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 229940124307 fluoroquinolone Drugs 0.000 abstract 1
- 229940041028 lincosamides Drugs 0.000 abstract 1
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 1
- 229940041033 macrolides Drugs 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 abstract 1
- 229960001180 norfloxacin Drugs 0.000 abstract 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 abstract 1
- 229960001699 ofloxacin Drugs 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 abstract 1
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 abstract 1
- 229940041153 polymyxins Drugs 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 229960000611 pyrimethamine Drugs 0.000 abstract 1
- WKSAUQYGYAYLPV-UHFFFAOYSA-N pyrimethamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1 WKSAUQYGYAYLPV-UHFFFAOYSA-N 0.000 abstract 1
- 150000007660 quinolones Chemical class 0.000 abstract 1
- 229960003600 silver sulfadiazine Drugs 0.000 abstract 1
- 229960002673 sulfacetamide Drugs 0.000 abstract 1
- SKIVFJLNDNKQPD-UHFFFAOYSA-N sulfacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 SKIVFJLNDNKQPD-UHFFFAOYSA-N 0.000 abstract 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 abstract 1
- 229960000654 sulfafurazole Drugs 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- 150000003456 sulfonamides Chemical class 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 229940072172 tetracycline antibiotic Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- OTVAEFIXJLOWRX-NXEZZACHSA-N thiamphenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)C=C1 OTVAEFIXJLOWRX-NXEZZACHSA-N 0.000 abstract 1
- 229960003053 thiamphenicol Drugs 0.000 abstract 1
- 229960004885 tiamulin Drugs 0.000 abstract 1
- UURAUHCOJAIIRQ-QGLSALSOSA-N tiamulin Chemical compound CCN(CC)CCSCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]23CC[C@@H](C)[C@]1(C)[C@@H]2C(=O)CC3 UURAUHCOJAIIRQ-QGLSALSOSA-N 0.000 abstract 1
- 229960000707 tobramycin Drugs 0.000 abstract 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45620103P | 2003-03-20 | 2003-03-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5611165A2 true CO5611165A2 (es) | 2006-02-28 |
Family
ID=33030090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO05094077A CO5611165A2 (es) | 2003-03-20 | 2005-09-16 | Composicion farmaceutica dispersable para el trataiento de mastitis y trastornos oticos |
Country Status (19)
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020035107A1 (en) * | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
| DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
| US8992980B2 (en) * | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
| MXPA05005995A (es) * | 2002-12-02 | 2006-01-27 | Byocoat Entpr Inc | Composicion y metodo para tratar una enfermedad fungica en una planta. |
| AU2004218353C1 (en) * | 2003-03-05 | 2011-02-24 | Byocoat Enterprises, Inc. | Antimicrobial solution and process |
| EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
| MXPA06012215A (es) * | 2004-04-22 | 2007-04-19 | Pfizer Prod Inc | Metodo de estabilizacion de la sal sodica cefovecina desordenada. |
| DE102004021281A1 (de) * | 2004-04-29 | 2005-11-24 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
| DE102004030409A1 (de) * | 2004-06-23 | 2006-01-26 | Boehringer Ingelheim Vetmedica Gmbh | Neue Verwendung von Meloxicam in der Veterinärmedizin |
| US7854943B2 (en) * | 2004-06-24 | 2010-12-21 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| US7858115B2 (en) * | 2004-06-24 | 2010-12-28 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| US7618651B2 (en) * | 2004-06-24 | 2009-11-17 | Idexx Laboratories | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
| DE102005055385A1 (de) * | 2004-12-09 | 2006-06-14 | Bayer Healthcare Ag | Arzneimittel zur hygienischen Applikation im Ohr |
| AT501376B1 (de) * | 2005-01-17 | 2010-11-15 | Pregenzer Bruno | Glucokortikoid-hältiges arzneimittel |
| SG166115A1 (en) * | 2005-09-30 | 2010-11-29 | Boehringer Ingelheim Vetmed | Pharmaceutical preparation containing meloxicam |
| US7976873B2 (en) | 2006-05-10 | 2011-07-12 | Medtronic Xomed, Inc. | Extracellular polysaccharide solvating system for treatment of bacterial ear conditions |
| US7959943B2 (en) | 2006-05-10 | 2011-06-14 | Medtronics Xomed, Inc. | Solvating system and sealant for medical use in the middle or inner ear |
| US7993675B2 (en) | 2006-05-10 | 2011-08-09 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use in the sinuses and nasal passages |
| US20070264296A1 (en) * | 2006-05-10 | 2007-11-15 | Myntti Matthew F | Biofilm extracellular polysachharide solvating system |
| AU2007298511B2 (en) * | 2006-07-10 | 2013-03-21 | Advanced Enzyme Technologies Limited | Compositions for prevention and treatment of mastitis and metritis |
| BRPI0721211A2 (pt) * | 2007-02-08 | 2013-01-15 | Medtronic Xomed Inc | uso de um tensoativo e um selante mÉdico, mÉtodo para tratar as condiÇÕes de ouvido, nariz e garganta, e, composiÇço |
| US8088095B2 (en) | 2007-02-08 | 2012-01-03 | Medtronic Xomed, Inc. | Polymeric sealant for medical use |
| BRPI0700969A (pt) * | 2007-03-22 | 2008-11-04 | Ouro Fino Participacoes E Empr | composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia |
| WO2009045456A1 (en) * | 2007-10-03 | 2009-04-09 | Byocoat Enterprises, Inc. | Compositions and methods for treating mastitis |
| WO2009152374A2 (en) | 2008-06-12 | 2009-12-17 | Medtronic Xomed, Inc. | Method for treating chronic wounds |
| US8318817B2 (en) * | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| EP2346324A4 (en) | 2008-10-06 | 2012-10-10 | Microbial Defense Systems Llc | ANTIMICROBIAL COMPOSITION AND METHODS OF MAKING AND USING |
| CN101953784B (zh) * | 2009-07-16 | 2012-02-08 | 中国农业大学 | 含阿莫西林、硫酸粘菌素和泼尼松龙的兽用混悬液及其制备方法 |
| US9101529B2 (en) | 2009-10-12 | 2015-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Containers for compositions comprising meloxicam |
| WO2011107150A1 (en) | 2010-03-03 | 2011-09-09 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
| US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
| EP3456200B1 (en) | 2011-05-10 | 2023-05-03 | Next Science IP Holdings Pty Ltd | Article having an antimicrobial solid and use thereof |
| BRPI1103782A2 (pt) * | 2011-08-19 | 2013-07-30 | Eurofarma Lab Ltda | produto veterinÁrio para tratamento de mastite, pre composiÇço antibiàtica a anti inflamatària, kit, mÉtodo de preparaÇço uso e mÉtodo de tratamento de mastite |
| CN102784161A (zh) * | 2012-08-01 | 2012-11-21 | 张吉川 | 一种治疗急慢性中耳炎的特效滴耳液 |
| CA3042642A1 (en) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
| US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| AU2015336065A1 (en) | 2014-10-20 | 2017-05-04 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
| CN104825474B (zh) * | 2015-04-30 | 2018-02-06 | 中国农业科学院兰州畜牧与兽药研究所 | 一种治疗动物体表损伤的药物组方及其制备工艺 |
| US9987362B2 (en) * | 2015-05-06 | 2018-06-05 | Zoetis Services Llc | Hydrogel formulation with mild adhesion |
| US10434097B1 (en) | 2015-09-14 | 2019-10-08 | Gateway Biotechnology, Inc. | Methods and compositions for treating hearing disorders |
| JP7217700B2 (ja) | 2016-09-13 | 2023-02-03 | アラーガン、インコーポレイテッド | 安定化非タンパク質クロストリジウム毒素組成物 |
| CN107252441A (zh) * | 2017-08-07 | 2017-10-17 | 咸阳职业技术学院 | 一种治疗奶牛乳腺炎的药物组合物及其制备方法 |
| US11918653B2 (en) * | 2017-12-22 | 2024-03-05 | Dompé Farmaceutici S.P.A. | Triglyceride otic formulations and uses thereof |
| EP3934618B1 (en) * | 2019-03-06 | 2026-04-29 | Zoetis Services LLC | Ready-to-use injectable formulations |
| JP2022546036A (ja) | 2019-08-27 | 2022-11-02 | ケーアイ ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー | 疼痛治療に有用な化合物 |
| CN116421731B (zh) * | 2023-04-07 | 2025-09-23 | 佛山市南海东方澳龙制药有限公司 | 用于防治奶牛乳房炎的药物组合物及其制备方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3636194A (en) * | 1969-10-23 | 1972-01-18 | Douglas G Parizeau | Composition and method for treating mastitis with therapeutic agents |
| DE2063896A1 (de) * | 1970-12-28 | 1972-07-20 | Dynamit Nobel Ag, 5210 Troisdorf | Salbengrundlagen auf der Basis von Triglyceriden gesättigter mittelkettiger Fettsäuren und Verfahren zu deren Herstellung |
| IT1190445B (it) * | 1985-11-08 | 1988-02-16 | Fatro Spa | Composizioni veterinarie a base di agenti antimicrobici e loro impiego |
| ES2079994B1 (es) * | 1992-10-07 | 1996-08-01 | Cusi Lab | Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica. |
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| DK0786986T3 (da) * | 1994-10-26 | 2002-04-29 | Novartis Ag | Anvendelse af en umættet fedtalkohol |
| US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
| CA2222138C (en) * | 1995-05-25 | 2008-10-14 | G.D. Searle & Co. | Method of preparing 3-haloalkyl-1h-pyrazoles |
| WO1996039146A1 (en) * | 1995-06-06 | 1996-12-12 | Bayer Corporation | Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions |
| US5756529A (en) * | 1995-09-29 | 1998-05-26 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies |
| AP9700912A0 (en) * | 1996-01-11 | 1997-01-31 | Smithkline Beecham Corp | Novel cycloalkyl substituted imidazoles |
| GEP20032998B (en) * | 1996-04-12 | 2003-06-25 | Searle & Co | Substituted Benzenesulfonamide Derivatives as Prodrugs of Cox-2 Inhibitors |
| RU2156131C1 (ru) * | 1996-06-21 | 2000-09-20 | Беляев Юрий Евгеньевич | Полуфабрикат для получения основы лекарственного средства, основы лекарственного средства из этого полуфабриката (варианты) и лекарственное средство на этой основе (варианты) |
| US5736151A (en) * | 1996-12-09 | 1998-04-07 | Pharmacia & Upjohn Company | Antibiotic oil suspensions |
| US6307047B1 (en) * | 1997-08-22 | 2001-10-23 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| US6440964B1 (en) * | 1998-09-30 | 2002-08-27 | Alcon Manufacturing, Ltd. | Compositions and methods for treating ophthalmic and otic infections |
| AR020660A1 (es) * | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Composiciones antibioticas para el tratamiento de ojos, oidos y nariz |
| US6509327B1 (en) * | 1998-09-30 | 2003-01-21 | Alcon Manufacturing, Ltd. | Compositions and methods for treating otic, ophthalmic and nasal infections |
| US6395746B1 (en) * | 1998-09-30 | 2002-05-28 | Alcon Manufacturing, Ltd. | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
| US6676930B2 (en) * | 1999-11-28 | 2004-01-13 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| US7064132B2 (en) * | 1999-11-28 | 2006-06-20 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis external |
| JP2003523958A (ja) * | 1999-12-23 | 2003-08-12 | ニトロメド インコーポレーテッド | ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−2の阻害剤、組成物ならびに使用法 |
| US20010049366A1 (en) * | 2000-02-09 | 2001-12-06 | Alcon Universal Ltd. | Topical solution formulations containing an antibiotic and a corticosteroid |
| WO2001072298A1 (en) * | 2000-03-27 | 2001-10-04 | The General Hospital Corporation | Treatments for immune-mediated ear disorders |
| EP1282435A2 (en) * | 2000-05-12 | 2003-02-12 | Immunex Corporation | Interleukin-1 inhibitors in the treatment of diseases |
| EP1353664A2 (en) * | 2000-06-08 | 2003-10-22 | The Board Of Regents, The University Of Texas System | Heterocycle derivatives and methods of use for treating anthrax infection |
| CA2410632A1 (en) * | 2000-06-22 | 2001-12-27 | David S. Garvey | Nitrosated and nitrosylated taxanes, compositions and methods of use |
| US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
-
2004
- 2004-03-05 US US10/795,191 patent/US20040214753A1/en not_active Abandoned
- 2004-03-09 CL CL200400471A patent/CL2004000471A1/es unknown
- 2004-03-10 WO PCT/IB2004/000802 patent/WO2004082719A1/en not_active Ceased
- 2004-03-10 CN CNA2004800075515A patent/CN1761486A/zh active Pending
- 2004-03-10 EP EP04719029A patent/EP1608406A1/en not_active Withdrawn
- 2004-03-10 BR BRPI0408559-0A patent/BRPI0408559A/pt not_active IP Right Cessation
- 2004-03-10 MX MXPA05010019A patent/MXPA05010019A/es not_active Application Discontinuation
- 2004-03-10 KR KR1020057017520A patent/KR100765614B1/ko not_active Expired - Fee Related
- 2004-03-10 AU AU2004222518A patent/AU2004222518A1/en not_active Abandoned
- 2004-03-10 RU RU2005126363/14A patent/RU2321423C2/ru not_active IP Right Cessation
- 2004-03-10 CA CA002519589A patent/CA2519589A1/en not_active Abandoned
- 2004-03-10 NZ NZ541780A patent/NZ541780A/en unknown
- 2004-03-10 JP JP2006506360A patent/JP2006520778A/ja not_active Abandoned
- 2004-03-18 UY UY28236A patent/UY28236A1/es not_active Application Discontinuation
- 2004-03-18 AR ARP040100904A patent/AR043651A1/es not_active Application Discontinuation
- 2004-03-19 TW TW093107484A patent/TWI265809B/zh not_active IP Right Cessation
-
2005
- 2005-08-16 ZA ZA200506531A patent/ZA200506531B/en unknown
- 2005-09-16 CO CO05094077A patent/CO5611165A2/es not_active Application Discontinuation
- 2005-10-17 NO NO20054777A patent/NO20054777L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| UY28236A1 (es) | 2004-11-08 |
| MXPA05010019A (es) | 2005-11-17 |
| JP2006520778A (ja) | 2006-09-14 |
| AR043651A1 (es) | 2005-08-03 |
| NZ541780A (en) | 2008-06-30 |
| ZA200506531B (en) | 2006-11-29 |
| WO2004082719A1 (en) | 2004-09-30 |
| CN1761486A (zh) | 2006-04-19 |
| KR20050114245A (ko) | 2005-12-05 |
| CA2519589A1 (en) | 2004-09-30 |
| RU2321423C2 (ru) | 2008-04-10 |
| RU2005126363A (ru) | 2006-05-10 |
| US20040214753A1 (en) | 2004-10-28 |
| TW200507852A (en) | 2005-03-01 |
| BRPI0408559A (pt) | 2006-03-21 |
| CL2004000471A1 (es) | 2005-04-22 |
| TWI265809B (en) | 2006-11-11 |
| EP1608406A1 (en) | 2005-12-28 |
| NO20054777L (no) | 2005-10-17 |
| AU2004222518A1 (en) | 2004-09-30 |
| KR100765614B1 (ko) | 2007-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR043651A1 (es) | Composicion farmaceutica dispersable para el tratamiento de mastitis y trastornos oticos | |
| CO5611169A2 (es) | Formulacion dispersable de un agente antiinflamatorio | |
| ES2937023T3 (es) | Agente de suspensión acuosa que comprende nanopartículas de glucocorticosteroides | |
| CA2477044A1 (en) | Ophthalmic formulation with gum system | |
| ZA200401593B (en) | Aerosolized decongestants for the treatment of sinusitis. | |
| EP2211913A4 (en) | SYSTEMIC ADMINISTRATION OF CHLOROTOXIN AGENTS FOR THE DIAGNOSIS AND TREATMENT OF TUMORS | |
| BR112021021904A2 (pt) | Preparações de fator da coagulação para liberação em tecido do trato intestinal usando um dispositivo de liberação de fármacos ingerível | |
| JP2015524444A5 (cg-RX-API-DMAC7.html) | ||
| JP2018522070A (ja) | 白内障の処置用組成物 | |
| JP6509812B2 (ja) | ジブチルヒドロキシトルエンの安定化方法 | |
| JP2019147802A (ja) | ジブチルヒドロキシトルエンの安定化方法 | |
| BR0013719A (pt) | Dosagem oral de liberaçâo controlada, apropriada para administração oral | |
| BRPI0413478A (pt) | solução farmacêutica aquosa compreendendo oximetazolina e/ou xilometazolina | |
| CA2896578A1 (en) | Carrier and pharmaceutical compositions for intrasinal delivery and uses thereof | |
| JP6724106B2 (ja) | クロルフェニラミン又はその塩の安定化方法 | |
| WO2015137328A1 (ja) | ジブチルヒドロキシトルエンの安定化方法 | |
| JP2006039529A (ja) | コンタクトレンズ用組成物 | |
| WO2016063265A2 (pt) | Formulação tópica para o tratamento de infeções na pele ou mucosas, método de preparação e seus usos | |
| JP6618262B2 (ja) | ジブチルヒドロキシトルエンの安定化方法 | |
| JP2011121983A (ja) | 粘膜の疾患および障害の予防および処置のための液体製剤 | |
| WO2020044114A3 (en) | Methotrexate pharmaceutical composition | |
| Maljkovic et al. | CASE REPORT: Laser-Assisted Treatment of Sialolithiasis | |
| JP2005239691A (ja) | トラニラスト含有医薬組成物 | |
| CN203829288U (zh) | 新型泪道探通冲洗针 | |
| BRPI0414223A (pt) | uso de extratos de gentiana lutea como um agente antimicrobiano |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |